FDA Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Asthma Therapy
Research from University of Antwerp, Department of Pulmonary Medicine in the area of asthma therapy published
March 15th, 2007
A report, "Glucocorticosteroids as antioxidants in treatment of asthma and COPD. New application for an old medication," is newly published data in Steroids. "Inhaled corticosteroids (ICS) are the standard of care in asthma and are widely used in the treatment of patients with COPD. The influence of steroids on inflammatory processes has long been established since glucocorticoids and their receptor belong to the regulatory network involved in inhibition of several inflammatory pathways," researchers in Antwerp, Belgium report. "Inflammatory processes are usually accompanied by an increased oxidative burden followed by a depletion of antioxidants. Therefore, the effects...
Source: FDA Law Weekly (2007-03-15)
|
